Natural Capsules Ltd 14 Nov 2026 12:00 AM
Natural Capsules Ltd consolidated sales up 5.01% on year in Q2FY2027,
Natural Capsules Ltd share price gained 1.36% to Rs 156.1 after the company`s net profit tanked by 26.48% to Rs 4.22 crore, while revenue from operations slightly gained 5.01% to Rs 51.15 crore in Q2FY27 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, gaining 6.82%. It has improved by 2.52% over last one week and ticked higher by 5.98% in last one month while the market capitalization of Natural Capsules Ltd has edged up by 12.30% and 3.89% in the same period respectively. Profit before tax (PBT) of Natural Capsules Ltd stood at Rs 4.58 crore in Q2 FY27, tumbling by 40.52% year-on-year, and crashing by 21.44% quarter-on-quarter. EBITDA came in at Rs 3 crore, tanking 371.15% YoY and rallying 196.84% sequentially. Total expenses saw a slight increase of 2.10% to Rs 53.01 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 27.69 crore, slightly declining by 4.25% YoY, while employee benefits expense was at Rs 5.67 crore, improving by 8.21% YoY. For FY26, revenue from operations advanced 10.63% to Rs 187.2 crore, while net profit witnessed a sharp fall of 4077.42% to Rs 24.66 crore, compared to previous FY. EBITDA soared by 2384% to Rs 3.29 crore, and PBT tumbled by 1100.72% to Rs 27.92 crore compared to previous FY. The company`s consolidated net cash flow from operating activities stood at Rs 10.92 crore in FY26, as against Rs 26.75 crore in FY25. Natural Capsules Ltd nosedived by 23.87% in last one year, underperforming the benchmark BSE Sensex which has softened by 3.42% during the same period.
Natural Capsules Ltd 06 Nov 2026 12:00 AM
Natural Capsules Limited to review financial results at board meeting on November 13, 2026,
Natural Capsules Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The company also stated that the trading window for equity shares has been closed for designated persons and their immediate relatives since October 1, 2026, and will remain so until 48 hours after the financial results are declared.
Natural Capsules Ltd 09 Oct 2026 12:00 AM
Natural Capsules confirms regulatory compliance for Q3 2026 with Cameo Corporate Services,
Natural Capsules Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 9, 2026, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, with Cameo Corporate Services Limited acting as the Registrar & Share Transfer Agent.
Natural Capsules Ltd 25 Sep 2026 12:00 AM
Natural Capsules closes trading window for insiders ahead of September 2026 results,
Natural Capsules Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for equity shares will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the quarter ended September 30, 2026, with the board meeting date to be announced later.
Natural Capsules Ltd 09 Sep 2026 12:00 AM
Natural Capsules shareholders approved a preferential equity share issuance at a meeting,
Natural Capsules Limited convened its 1st Extraordinary General Meeting on Wednesday, September 9, 2026, via video conference, where shareholders approved a special resolution for the issuance of equity shares and warrants convertible into equity shares on a preferential basis. Mr. Tekkar Yashwanth Prabhu, Chairman, presided over the meeting, which was attended by 31 members constituting the requisite quorum, and Mr. Sunil L Mundra, Managing Director, addressed the meeting regarding the preferential issue. The results of the voting will be declared upon receipt of the Scrutinizer`s report and submitted to the stock exchanges separately.
Subscribe for our
newsletter
Open Account Now